• <table id="gigg0"></table>
  • west china medical publishers
    Keyword
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Keyword "Graves病" 2 results
    • Correlation between Chinese Population Cytotoxic T Lymphocytes Associated Antigen-4 Gene Exon-1 & Promoter Polymorphisms and Graves’ Disease: A Meta-Analysis

      Objective To systematically evaluate correlation between exon-1 (locus 49, A/G) and promoter (locus -318, C/T) polymorphisms of Chinese population cytotoxic T lymphocytes associated antigen-4 (CTLA-4) gene and Graves’ Disease (GD). Methods Relevant studies were electronically searched in CNKI, VIP, CBM, PubMed, EMbase and The Cochrane Library from 1980.1 to 2011.12. According to the inclusion and exclusion criteria, we selected and screened all case-control studies on the correlation between CTLA-4 exon -1 (locus 49, A/G) and promoter (locus -318, C/T) polymorphisms of Chinese population and GD. Then we extracted the data and assessed the methodological quality of the included studies. Meta-analysis was performed using RevMan 5.0 and STATA 12.0 software. Results (1) Ten studies on exon-1 were included. Results of meta-analyses showed that Chinese population with genotype G/G had a higher GD risk than those with genotype A/A (OR=3.38, 95%CI 2.07 to 5.51) and A/G (OR=1.72, 95%CI 1.31 to 2.25). Also, the allele G showed significant association with increased GD risk compared to the allele A (OR=1.87, 95%CI 1.44 to 2.41). (2) Five studies on promoter-318 were included. Results of meta-analyses showed that Chinese population with genotype T/T presented no increased relative risk compared to those with genotype C/C (OR=0.75, 95%CI 0.26 to 2.12) or C/T (OR=0.92, 95%CI 0.31 to 2.73). Meanwhile, the allele T showed no increased relative risk compared to the allele C (OR=0.83, 95%CI 0.61 to 1.12). Conclusion The allele G at the locus 49 of exon -1 of Chinese population is significantly associated with increased GD risks, yet the correlation between promoter –318 C/T polymorphism and GD hasn’t been demonstrated. Due to the limited quality and quantity of the included studies, more high-quality studies are needed to test the above conclusion.

      Release date:2016-09-07 10:58 Export PDF Favorites Scan
    • 免疫球蛋白G4相關性甲狀腺疾病

      免疫球蛋白 G4 相關性疾病(immunoglobulin G4-related disease,IgG4-RD)是本世紀初新認識的可累及包括內分泌系統特別是甲狀腺的全身多器官系統疾病,以免疫介導的纖維化炎癥為主要病理特征。免疫球蛋白 G4 相關甲狀腺疾病(immunoglobulin G4-related thyroid disease,IgG4-RTD)是很少被考慮到的一類甲狀腺疾病,既可單獨累及甲狀腺也可同時累及其他器官。目前認為 IgG4-RTD 包括 4 種亞型:Riedel 甲狀腺炎、橋本甲狀腺炎的纖維樣變型、免疫球蛋白 G4(immunoglobulin G4,IgG4)相關性橋本甲狀腺炎和 Graves 病合并 IgG4 升高。其診斷較為復雜,需結合臨床表現、組織學特征和血清學證據綜合判斷。大多數情況下,可根據經典的組織病理學表現診斷 IgG4-RTD,因此強烈推薦在治療前進行活檢。IgG4-RTD 的治療包括藥物治療和手術治療,雖然可能需要進一步證據,類固醇仍是一線治療藥物。他莫昔芬和利妥昔單抗是類固醇抵抗患者的二線治療藥物。對于有壓迫癥狀患者應選擇行甲狀腺切除。到目前為止,該病的病理生理機制尚未完全明確,早期及時診斷、早期治療可明顯改善預后。

      Release date:2018-05-24 02:12 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南